THE WHAT? L’Oréal has reported a 19 percent rise in sales to 9.06 billion euros (US $9.8 billion) in Q1, driven by strong sales for its Luxe division.
THE DETAILS Per category, L’Oréal Luxe rose 25.1 percent on a reported basis, followed by Professional Products at 22.7 percent, Active Cosmetics at 22.4 percent and Consumer Products at 11.1 percent.
Geographically, Latin America grew 33.9 percent, followed by North America, SAPMENA-SSA, North Asia and Europe at 21.5, 18.7, 18, and 15.8 percent respectively.
L’Oréal Luxe achieved balanced growth across geographic Zones. At the end of March, the Division held a historic market share in North Asia and, moreover, outperformed a dynamic market in North America. L’Oréal Luxe also recorded an excellent first quarter in Europe.
The Division gained market share thanks to the strength and complementarity of its brand portfolio.
THE WHY? L’Oréal has been working to evolve its product portfolio towards the premium sector, with Luxe posting the strongest sales.
Discussing the quarter growth, Nicolas Hieronimus, CEO of L’Oréal, said, “Against the backdrop of the invasion of Ukraine and strengthened sanitary measures in China, L’Oréal had a strong first quarter, with strong growth in sales, at +13.5% like-for-like and +19.0% reported.”
He continued, “In the first three months of the year, the growth trend continued in the global beauty market, with consumer purchasing behaviour unaffected by inflation. L’Oréal pursued its premiumisation and innovation strategy and continued to outpace the beauty market across all Zones and Divisions, recording strong growth by volume and value.
“L’Oréal Luxe, Professional Products and Active Cosmetics all achieved double-digit growth, and our Consumer Products Division again outperformed the market despite supply-chain challenges. We made the most of our omnichannel strategy, with a clear revival in offline sales while e-commerce 2 continued to grow, representing 25.8% of sales.”
Aesthetic injectable companies refer to businesses or companies that specialize in manufacturing, distributing, or providing aesthetic injectable products and services. These companies focus on developing and supplying injectable substances used for cosmetic purposes, typically administered by qualified medical professionals. Aesthetic injectable companies play a crucial role in the field of aesthetic medicine and cosmetic dermatology by offering a variety of injectable products designed to enhance facial features, reduce wrinkles, and improve overall skin appearance.
Key aspects of aesthetic injectable companies include:
-
Product Development: These companies research, develop, and manufacture aesthetic injectables such as dermal fillers, botulinum toxins (e.g., Botox), collagen stimulators, and other specialized formulations. They often innovate new products to meet evolving market demands and technological advancements.
-
Distribution and Sales: Aesthetic injectable companies distribute their products through authorized channels, including healthcare providers, medical spas, and aesthetic clinics. They may also sell directly to licensed professionals who administer these treatments.
-
Regulatory Compliance: Due to the medical nature of their products, aesthetic injectable companies adhere to strict regulatory guidelines and obtain necessary approvals from health authorities (e.g., FDA in the United States) to ensure safety, efficacy, and quality standards.
-
Training and Support: Many companies provide training and educational support to healthcare professionals on the proper use, administration techniques, and safety protocols associated with their injectable products. This ensures that practitioners can deliver treatments effectively and safely.
-
Customer Support: Aesthetic injectable companies offer customer support services to healthcare providers and consumers, addressing inquiries, providing product information, and assisting with product usage and troubleshooting.
